J
Jung Hwan Yoon
Researcher at New Generation University College
Publications - 411
Citations - 13853
Jung Hwan Yoon is an academic researcher from New Generation University College. The author has contributed to research in topics: Hepatocellular carcinoma & Hepatitis B virus. The author has an hindex of 56, co-authored 370 publications receiving 11221 citations. Previous affiliations of Jung Hwan Yoon include Seoul National University Hospital & Mayo Clinic.
Papers
More filters
Journal ArticleDOI
Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease
Jeong Hoon Lee,Donghee Kim,Hwa Jung Kim,Hwa Jung Kim,Chang Hoon Lee,Jong In Yang,Won Kim,Yoon Jun Kim,Jung Hwan Yoon,Sang Heon Cho,Myung-Whun Sung,Hyo Suk Lee +11 more
TL;DR: HSI is a simple, efficient screening tool for NAFLD that may be utilized for selecting individuals for liver ultrasonography and for determining the need for lifestyle modifications.
Journal ArticleDOI
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma.
Masatoshi Kudo,Kazuho Imanaka,Nobuyuki Chida,Kohei Nakachi,Won Young Tak,Tadatoshi Takayama,Jung Hwan Yoon,Takeshi Hori,Hiromitsu Kumada,Norio Hayashi,Shuichi Kaneko,Hirohito Tsubouchi,Dong Jin Suh,Junji Furuse,Takuji Okusaka,Katsuaki Tanaka,Osamu Matsui,Michihiko Wada,Iku Yamaguchi,Toshio Ohya,Gerold Meinhardt,Kiwamu Okita +21 more
TL;DR: This trial, conducted prior to the reporting of registrational phase III trials, found that sorafenib did not significantly prolong TTP in patients who responded to TACE.
Journal ArticleDOI
Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma
Joon Hyeok Lee,Jeong Hoon Lee,Young-Suk Lim,Jong Eun Yeon,Tae Jin Song,Su Jong Yu,Geum-Youn Gwak,Kang Mo Kim,Yoon Jun Kim,Jae Won Lee,Jung Hwan Yoon +10 more
TL;DR: In patients who underwent curative treatment for HCC, adjuvant immunotherapy with activated CIK cells increased recurrence-free and overall survival.
Journal ArticleDOI
Nonalcoholic fatty liver disease is associated with coronary artery calcification
Donghee Kim,Su Yeon Choi,Eun Ha Park,Whal Lee,Jin Hwa Kang,Won Kim,Yoon Jun Kim,Jung Hwan Yoon,Sook Hyang Jeong,Dong Ho Lee,Hyo Suk Lee,Joseph J. Larson,Terry M. Therneau,W. Ray Kim +13 more
TL;DR: Patients with NAFLD are at increased risk for coronary atherosclerosis independent of classical coronary risk factors, including visceral adiposity, according to this data, which suggest thatNAFLD might be an independent risk factor for coronary artery disease.
Journal ArticleDOI
Radiofrequency Ablation of Hepatocellular Carcinoma as First-Line Treatment: Long-term Results and Prognostic Factors in 162 Patients with Cirrhosis
Dong Ho Lee,Jeong Min Lee,Jae Young Lee,Se Hyung Kim,Jung Hwan Yoon,Yoon Jun Kim,Joon Koo Han,Byung Ihn Choi +7 more
TL;DR: RFA is a safe and effective first-line treatment for early-stage HCC, with a 5-year survival rate of 67.9%.